Results 21 to 30 of about 8,454 (213)
Efficacy of iontophoresis-assisted epithelium-on corneal cross-linking for keratoconus [PDF]
International Journal of Ophthalmology, 2018 Corneal cross-linking (CXL) is a noninvasive therapeutic procedure for keratoconus that is aimed at improving corneal biomechanical properties by induction of covalent cross-links between stromal proteins.
Hong-Zhen Jia, Xiu-Jun Peng
doaj +1 more source
Collagen Crosslinking for Keratoconus: Cellular Signaling Mechanisms
Biomolecules, 2023 Collagen crosslinking (CXL) is a widely used treatment to halt the progression of keratoconus (KC). Unfortunately, a significant number of patients with progressive KC will not qualify for CXL, including those with corneas thinner than 400 µm.
Dimitrios Karamichos +3 more
doaj +1 more source
PACK-CXL: Defining CXL for Infectious Keratitis
Journal of Refractive Surgery, 2014 THE CONCEPT OF CXL In 1998, the proof-of-principle for corneal collagen cross-linking (CXL) was born from such a “simple” concept. Combining ultraviolet-A light and a chromophore (vitamin B2, riboflavin), the cornea could be stiffened within a mere half hour and progressive thinning diseases such as keratoconus could be halted.1,2 Although still ...
Hafezi, Farhad, Randleman, J. Bradley
openaire +4 more sources
Gülhane Tıp Dergisi, 2022 Aims:To evaluate the efficacy and safety of transepithelial diluted alcohol and iontophoresis-assisted corneal cross-linking (DAI-CXL) and compare 24-month visual and topographic outcomes with accelerated CXL using hypo-osmolar riboflavin (A-CXL) in ...
Betül Seher Uysal +4 more
doaj +1 more source
Complications of corneal collagen cross-linking
Indian Journal of Ophthalmology, 2022 Corneal collagen cross-linking (CXL) is an effective treatment for arresting progression in patients with keratoconus. CXL was approved by United States Food and Drug Administration for the treatment of progressive keratoconus in 2016. It is a relatively
Richa Agarwal, Parul Jain, Ritu Arora
doaj +1 more source
Nonlinear optical crosslinking (NLO CXL) for correcting refractive errors. [PDF]
, 2020 Ultraviolet A (UVA) light-based photoactivation of riboflavin (Rf) to induce corneal crosslinking (CXL) and mechanical stiffening is now a well-known treatment for corneal ectasia and Keratoconus that is being used in a topographically guided ...
Bradford, Samantha +9 more
core +1 more source
Journal of Ophthalmology, 2022 Introduction. To compare accelerated and standard corneal collagen cross-linking (CXL) treatments in experimental Aspergillus keratitis models. Methods. Twenty-six New Zealand rabbits were divided into two groups: a 1% voriconazole combined with standard
Anji Wei +3 more
doaj +1 more source
, 2023 Purpose; To evaluate the efficacy and safety of silicone hydrogel contact lens-assisted corneal cross-linking (CL-CXL) and compare 12-month visual and topographic outcomes with accelerated CXL using hypo-osmolar riboflavin (A-CXL) in keratoconus patients
Uysal, Betul Seher +3 more
core +1 more source
Effect of corneal cross-linking surgery on corneal densitometry in patients with keratoconus
陆军军医大学学报, 2022 Objective To obtain and analyze the effect of corneal collagen crosslinking (CXL) on corneal densitometry (CD) in patients with keratoconus (KC) by using the Pentacam 3D anterior segment analysis system.
YANG Kunkun +5 more
doaj +1 more source
CXL.—The fluorescence of platinocyanides [PDF]
J. Chem. Soc., Trans., 1908 n ...
openaire +1 more source